Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach [PeerJ]

Aptamer-Mediated Antiviral Approaches for SARS-CoV-2

Frontiers Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Spike, S1, RBD, SARS-CoV-2 plasmids

Frontiers Are the integrin binding motifs within SARS CoV-2

Frontiers Endocytosis inhibitors block SARS-CoV-2 pseudoparticle infection of mink lung epithelium

New research on phagocytosis and SARS-CoV-2's spike protein

Frontiers Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii

Frontiers Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease